ChemicalBook > CAS DataBase List > (3S,4S)-Tofacitinib
(3S,4S)-Tofacitinib
(3S,4S)-Tofacitinib
- CAS No.1092578-47-6
- Chemical Name:(3S,4S)-Tofacitinib
- CBNumber:CB3970902
- Molecular Formula:C16H20N6O
- Formula Weight:312.37
- MOL File:Mol file
(3S,4S)-Tofacitinib Property
- Density 1.296
- storage temp. Store at -20°C
- solubility DMSO (Slightly), Methanol (Slightly)
- pka 6.04±0.60(Predicted)
- form Powder
- color Off-white to pink
- FDA UNII C3EP7ZZ9UQ
-
Symbol(GHS)
- Signal wordWarning
- Hazard statements H302-H315-H319-H335
- Precautionary statements P261-P280-P301+P312-P302+P352-P305+P351+P338
(3S,4S)-Tofacitinib Chemical Properties,Usage,Production
(3S,4S)-Tofacitinib Preparation Products And Raw materials
Raw materials
Preparation Products
Global(119)Suppliers
-
Supplier:
- Tel:18871490254
- Email:linda@hubeijusheng.com
- Country:CHINA
- ProdList:28172
- Advantage:58
-
Supplier:
- Tel:86-714-3992388
- Email:overseasales1@yongstandards.com
- Country:United States
- ProdList:14332
- Advantage:58
-
Supplier:
- Tel:+1-631-485-4226
- Email:inquiry@bocsci.com
- Country:United States
- ProdList:19552
- Advantage:58
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:factory@coreychem.com
- Country:China
- ProdList:29808
- Advantage:58
-
Supplier:
- Tel:+86-021-021-50872116<br/>+8613122107989
- Email:contact@fuxinpharm.com
- Country:China
- ProdList:10035
- Advantage:58
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32159
- Advantage:58
-
Supplier:
- Tel: +8613062833949
- Email:fred.wen@crcorporation.cn
- Country:China
- ProdList:8647
- Advantage:58
-
Supplier:
- Tel:571-86758373<br/>+8613588754946
- Email:sales@huarongpharm.com
- Country:CHINA
- ProdList:3148
- Advantage:58
-
Supplier:
- Tel: +8615391658522
- Email:overseasales@yongstandards.com
- Country:China
- ProdList:11922
- Advantage:58
-
Supplier:
- Tel:+86-852-30606658
- Email:market18@leapchem.com
- Country:China
- ProdList:43340
- Advantage:58
1092578-47-6, (3S,4S)-TofacitinibRelated Search:
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 19 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine R-afatinib Tofacitinib Impurity 20 (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile (3R,4R)-N,4-dimethyl-piperidin-3-amine TF-A 2-amino-4-fluoro-5-nitrobenzoic acid Ethyl S-4-chloro-3-hydroxybutyrate Tofacitinib Impurity 2 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity T
- (3S,4S)-托法替尼
- 药靶配体
- 现货
- (3RS,4RS)-托法替尼
- 杂质对照品
- 对照品-杂质对照品
- 化学试剂、精细化学品、医药中间体、材料中间体
- 托法替尼杂质
- 3-((3S,4S)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈
- 托法替尼杂质17单体
- (3S,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1(托法替布杂质)
- (3S,4S)-4-甲基-3-(甲基-7H-吡咯[2,3-D]嘧啶-4-基氨基)-Β-氧代-1-哌啶丙烷腈
- 托法替尼-IMQ
- 托法替尼-IMZ14
- (3S,4S)-托法替尼
- 托法替尼杂质C柠檬酸盐
- 3S,4S托法替布(托法替布M8对映异构体)
- 托法替尼-IMZ14、托法替尼异构体SS
- 托伐替尼杂质C
- (3S,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-Β-氧代-1-哌啶丙腈
- 托法替尼杂质339
- 枸橼酸托法替尼杂质C
- 托法替布杂质C
- 托法替尼杂质A 枸橼酸盐
- 托法替尼-Q
- SS-托法替尼API杂质
- (3S,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈
- 托法替尼 杂质 A
- 托法替尼杂质C枸橼酸盐
- 托法替尼柠檬酸杂质C
- SS-托法替尼API杂质 50MG
- 1092578-47-6
- Tofatinib impurity 15
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3S,4S)-
- (3S,4S)-Tofacitinib (Tofacitinib Impurity)
- Tofatinib Impurity C
- Azilsartan medoxomil impurity339
- Tofacitinib Impurity Q Citrate
- Tofacitinib Impurity 17 Monomer
- Tofacitinib impurity 11/(3S,4S)-Tofacitinib/3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile
- SIM2908 3-((3S,4S)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib 3S,4S
- Tofacitinib-15
- 2-isocyano-1-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone
- 15(3R4S,3S4R)
- (3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
- 3-((3S,4S)-4-methyl-3-(methyl(7Hpyrrolo[2,3-d]pyrimidin-4-yl)
- Tofacitinib Impurity C
- ent-Tofacitinib
- Tofacitinib Impurity C(3S,4S)
- Tofacitinib IMpurity C Citrate
- Tofacitinib IMpurity A
- SS-tofacitinib
- (3S,4S)-Tofacitinib
- (3S,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile
- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile